MTOR and neurodegenerative disease: Nevertheless, the mTOR pathway links several biological pathways underlying neurodegenerative diseases and therefore the ability of metformin to inhibit this signaling cascade endorses the argument that more mechanistic work using metformin and its inclusion in clinical trials should be positively considered.